AMGEN INC is 140.1x more valuable than Maze Therapeutics, Inc. by market capitalization ($183.41 B vs $1.31 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MAZE | AMGN |
|---|---|---|
| Market cap | $1.31 B | $183.41 B |
| US-listed rank | #2433 | #79 |
| Revenue (latest FY) | $167.50M | $36.75B |
| Net income (latest FY) | -$131.12M | $7.71B |
| Net margin | -78.3% | 21.0% |
| P/E (trailing FY) | - | 23.8 |
| SEC filings | 165 | 1,011 |
AMGEN INC is 140.1x more valuable than Maze Therapeutics, Inc. by market capitalization ($183.41 B vs $1.31 B).
In their latest fiscal years, Maze Therapeutics, Inc. reported $167.50M in revenue while AMGEN INC reported $36.75B.
Full pages: Maze Therapeutics, Inc. and AMGEN INC, or browse the full rankings.